5 Care at the time of the transplant
5.1 Transplant centres should review induction and immunosuppression regimens, taking into account the overall immunosuppression burden for patients in the context of COVID‑19.
5.2 If possible, admit patients earlier than usual, to allow time for COVID‑19 assessment before transplant and to minimise cold ischaemia time.
5.3 Assess patients for COVID‑19 on admission for their transplant:
5.4 Do not routinely request chest CT scans to screen for COVID‑19 in patients with no symptoms.
5.5 The transplant or immunosuppression should not start until the patient has a negative nasopharyngeal swab test result for SARS‑CoV‑2. NHS Blood and Transplant Kidney Advisory Group has given guidance on swab testing in its guidance for re-opening or expansion of kidney transplant programmes and COVID-19.
5.6 Be aware that a negative result does not definitely rule out infection and must be interpreted in the context of other assessments. Do not start the transplant or immunosuppression if the patient is likely to have COVID‑19 despite a negative test result.
5.7 If patients need dialysis after transplantation, do this in a COVID-19-secure area.